Los puntos clave no están disponibles para este artículo en este momento.
Extended-release buprenorphine (XR-Bup) is associated with reduced opioid use and opioid negative urine drug screens. Little is known about its use in outpatient addiction care provided within health systems.
Yarborough et al. (Sun,) studied this question.